Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Irinotecan × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 63 Pancreatic Neoplasms 29 Neoplasm Metastasis 20 Neuroblastoma 16 Colonic Neoplasms 16 Neoplasms 15 Stomach Neoplasms 13 Rectal Neoplasms 10 Sarcoma, Ewing 8 Rhabdomyosarcoma 7 Esophageal Squamous Cell Carcinoma 7 Ovarian Neoplasms 6 Sarcoma 5 Adenocarcinoma Of Esophagus 5 Small Cell Lung Carcinoma 4 Recurrence 4 Medulloblastoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Osteosarcoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Ependymoma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Adenocarcinoma 3 Wilms Tumor 2

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡